Ask the Expert: Understanding Your Risk of Melanoma Spreading: What You Should Know About New Testing  

Join us for an informative and interactive webinar with melanoma expert Elliott Campbell, MD, FAAD, to learn about CP-GEP testing and its potential role in melanoma care. This molecular test combines information about a patient’s tumor and age to help assess the risk of melanoma spreading to nearby lymph nodes.  
 
Dr. Campbell will explain how the test works, who may benefit from it, how results may inform decisions about sentinel lymph node biopsy, and what recent NCCN guideline updates mean for patients with early-stage melanoma. Whether you’re newly diagnosed or exploring your options, this session will help you better understand this testing option and how it may fit into your care journey. 
 

Speakers:

Dr. Elliott Harrison Campbell, MD, FAAD, is a board-certified dermatologist and board certified and fellowship-trained Mohs Micrographic Surgeon practicing at Dermatology Associates of Northern Kentucky. He completed his dermatology residency and fellowship training at the Mayo Clinic. During training at Mayo, Dr. Campbell received numerous awards, including the Mayo Brothers Award, the institution’s highest honor. 

Dr. Campbell has published extensively in cutaneous oncology, particularly in melanoma. His research interests include Mohs for melanoma and gene expression profiling for melanoma. He is actively involved in guideline work related to Mohs surgery and served as lead author of the 2026 dermatologic surgery antibiotic guideline update from 2008.